FAM83A在恶性肿瘤中的作用研究进展

口腔生物医学 ›› 2022, Vol. 13 ›› Issue (2): 125-129.

FAM83A在恶性肿瘤中的作用研究进展

徐佳妮¹,李轩¹,²,吉幻¹,钟旖³

1. 南京医科大学口腔疾病研究江苏省重点实验室
2. 南京医科大学附属口腔医院口腔综合科
3. 江苏省口腔医院病理科

收稿日期:2021-04-13 修回日期:2022-05-11 出版日期:2022-06-25 发布日期:2022-07-07
通讯作者: 钟旖 E-mail:236744209@qq.com
基金资助:
江苏省自然科学基金;江苏省卫健委医学科研项目

Research progress on FAM83A and its role in malignant tumors

Received:2021-04-13 Revised:2022-05-11 Online:2022-06-25 Published:2022-07-07

摘要/Abstract

摘要： 序列相似性为83的家族成员A（FAM83A）在多种恶性肿瘤中均有表达，参与肿瘤的发生、发展和转移等过程，与临床预后密切相关，是一种潜在的肿瘤特异性抗原。本文对FAM83A的结构特点、在恶性肿瘤发生发展中的作用以及临床应用前景进行综述。

关键词: 序列相似性为83的家族成员A, 恶性肿瘤, 发生发展, 预后

Abstract: Family with sequence similarity 83 member A is widely expressed in various tumors and participates in the occurrence and development of human tumors. In recent years, FAM83A，closely related to clinical outcomes, has been proved to be a potential tumor-specific antigen, which plays a significant role in malignant tumors. In this paper, the structure of FAM83A, its role in malignant tumors and the potential prospects in clinical application were reviewed.

Key words: FAM83A, neoplasm, prognosis

徐佳妮李轩吉幻钟旖. FAM83A在恶性肿瘤中的作用研究进展[J]. 口腔生物医学, 2022, 13(2): 125-129.

参考文献 35

[1]	Zhang J-T, Lin Y-C, Xiao B-F, et al. Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma[J]. Med Sci Monit. 2019;25:4264-72.
[2]	Zhang M, Huo C, Jiang Y, et al. AURKA and FAM83A are prognostic biomarkers and correlated with Tumor-infiltrating Lymphocytes in smoking related Lung Adenocarcinoma[J]. Journal of Cancer. 2021;12(6):1742-54.
[3]	Xu J, Lu W. FAM83A exerts tumor?suppressive roles in cervical cancer by regulating integrins[J]. Int J Oncol. 2020;57(2):509-21.
[4]	Hu H, Wang F, Wang M, et al. FAM83A is amplified and promotes tumorigenicity in non-small cell lung cancer via ERK and PI3K/Akt/mTOR pathways[J]. Int J Med Sci. 2020;17(6):807-14.
[5]	刘镭, 黄亮, 车清海, 等.乳腺癌高表达基因FAM83A的生物信息学分析[J]. 重庆医学. 2013;42(03):243-5.
[6]	Li Y, Dong X, Yin Y, et al. BJ-TSA-9, a novel human tumor-specific gene, has potential as a biomarker of lung cancer[J]. Neoplasia. 2005;7(12):1073-80.
[7]	Lee S-Y, Meier R, Furuta S, et al. FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice[J]. J Clin Invest. 2012;122(9):3211-20.
[8]	He J, Yu J. Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A[J]. Bioscience Reports. 2019;39(11).
[9]	Chen S, Huang J, Liu Z, et al. FAM83A is amplified and promotes cancer stem cell-like traits and chemoresistance in pancreatic cancer[J]. Oncogenesis. 2017;6(3):e300-e.
[10]	Liu PJ, Chen YH, Tsai KW, et al. Involvement of MicroRNA-1-FAM83A Axis Dysfunction in the Growth and Motility of Lung Cancer Cells[J]. Int J Mol Sci. 2020;21(22).
[11]	Gan J, Li Y, Meng Q. Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-small-Cell Lung Cancer[J]. Front Mol Biosci. 2020;7:572406.
[12]	Zhou F, Geng J, Xu S, et al. FAM83A signaling induces epithelial-mesenchymal transition by the PI3K/AKT/Snail pathway in NSCLC[J]. Aging. 2019;11(16):6069-88.
[13]	Wang Y, Xu R, Zhang D, et al. Circ-ZKSCAN1 regulates FAM83A expression and inactivates MAPK signaling by targeting miR-330-5p to promote non-small cell lung cancer progression[J]. Transl Lung Cancer Res. 2019;8(6):862-75.
[14]	Shi R, Jiao Z, Yu A, et al. Long noncoding antisense RNA FAM83A-AS1 promotes lung cancer cell progression by increasing FAM83A[J]. J Cell Biochem. 2019;120(6):10505-12.
[15]	Yu J, Hou M, Pei T. FAM83A Is a Prognosis Signature and Potential Oncogene of Lung Adenocarcinoma[J]. DNA Cell Biol. 2020;39(5):890-9.
[16]	Zhou F, Wang X, Liu F, et al. FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma[J]. Int J Clin Oncol. 2020;25(9):1612-23.
[17]	Zheng Y-W, Li Z-H, Lei L, et al. FAM83A Promotes Lung Cancer Progression by Regulating the Wnt and Hippo Signaling Pathways and Indicates Poor Prognosis[J]. Front Oncol. 2020;10:180-.
[18]	Wang G, Li X, Yao Y, et al. FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma[J]. Oncol Lett. 2021;21(4):297-.
[19]	Xiao G, Wang P, Zheng X, et al. FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14[J]. Cell Cycle. 2019;18(21):2972-85.
[20]	Nagini S. Breast Cancer: Current Molecular Therapeutic Targets and New Players[J]. Anticancer Agents Med Chem. 2017;17(2):152-63.
[21]	Liu L, Ma C, Xu Q, et al. A rapid nested polymerase chain reaction method to detect circulating cancer cells in breast cancer patients using multiple marker genes[J]. Oncol Lett. 2014;7(6):2192-8.
[22]	Bartel CA, Jackson MW. HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss[J]. PloS one. 2017;12(5):e0176778-e.
[23]	Liu C, Jiang Y, Han B. miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A[J]. Cancer Manag Res. 2020;12:12623-33.
[24]	Hu Z, Ma D. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications[J]. Cancer Med. 2018;7(10):5217-36.
[25]	Rong L, Li H, Li Z, et al. FAM83A as a Potential Biological Marker Is Regulated by miR-206 to Promote Cervical Cancer Progression Through PI3K/AKT/mTOR Pathway[J]. Front Med. 2020;7:608441.
[26]	Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management[J]. Nat Rev Gastroenterol Hepatol. 2019;16(10):589-604.
[27]	Liu C, Peng X, Li Y, et al. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma[J]. Biomed Pharmacother. 2020;123:109780.
[28]	Yu WS, Wang ZG, Guo RP, et al. Hepatocellular carcinoma progression is protected by miRNA-34c-5p by regulating FAM83A[J]. Eur Rev Med Pharmacol Sci. 2020;24(11):6046-54.
[29]	Mizrahi JD, Surana R, Valle JW, et al. Pancreatic cancer[J]. Lancet. 2020;395(10242):2008-20.
[30]	Parameswaran N, Bartel CA, Hernandez-Sanchez W, et al. A FAM83A Positive Feed-back Loop Drives Survival and Tumorigenicity of Pancreatic Ductal Adenocarcinomas[J].Scientific reports. 2019;9(1):13396-.
[31]	Zhou C, Liang Y, Zhou L, et al. TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signaling and autophagy via the MIR454-FAM83A-TSPAN1 axis in pancreatic cancer[J]. Autophagy. 2020:1-21.
[32]	Chen Y, Lu Y, Ren Y, et al. Starvation-induced suppression of DAZAP1 by miR-10b integrates splicing control into TSC2-regulated oncogenic autophagy in esophageal squamous cell carcinoma[J]. Theranostics. 2020;10(11):4983-96.
[33]	Huang GM, Zang HL, Geng YX, et al. LncRNA FAM83A-AS1 aggravates the malignant development of esophageal cancer by binding to miR-495-3p[J]. Eur Rev Med Pharmacol Sci. 2020;24(18):9408-15.
[34]	Jia J, Li H, Chu J, et al. LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis[J]. J Cancer. 2021;12(4):1200-11.
[35]	倪猛, 殷涛, 王旸, 等.FAM83A对胰腺癌细胞PANC-1干细胞样表型和放射敏感性的影响[J]. 中华放射医学与防护杂志. 2018;38(09):647-53.